Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

29 Apr 2022

Christy Leung

Share

This content is sponsored. It is intended for healthcare professionals only.

The gut microbiome is known to interact with infection and immunity, such as immune response after BCG vaccine and COVID-19 disease prognosis. Investigators are thus interested to learn whether certain gut microbiome composition can be prognostic indicators for adverse event occurrence and vaccine efficacy.

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026